10.1104/pp.107.114066 81 LuP.SangW
This review synthesizes evidence from about 120 preclinical/clinical studies sourced from PubMed, Scopus, and Web of Science using keywords (e.g., nutraceutical-drug interactions, bioavailability, CYP/P-gp modulation), prioritizing recent advances (20152024) alongside seminal works to contextualize mechanisms
Every patient responds differently, and factors like your starting dose, dosage adjustments, lifestyle, and unique body chemistry can influence how quickly you see results
Cognitive function did not decline in either group over the two-year period (175), suggesting that longer intervention trials are needed to determine whether long-chain omega-3 fatty acids have utility in the prevention of age-related cognitive decline